ImmuPharma plc (LON:IMM – Get Free Report)’s share price shot up 8.7% during trading on Monday . The stock traded as high as GBX 4.95 ($0.06) and last traded at GBX 4.28 ($0.05). 20,002,631 shares were traded during mid-day trading, an increase of 2% from the average session volume of 19,701,029 shares. The stock had previously closed at GBX 3.94 ($0.05).
ImmuPharma Trading Down 20.3 %
The stock’s 50 day moving average is GBX 1.92 and its 200 day moving average is GBX 1.78. The stock has a market capitalization of £19.57 million, a price-to-earnings ratio of -470.00 and a beta of 1.53.
About ImmuPharma
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
Read More
- Five stocks we like better than ImmuPharma
- How to Use Stock Screeners to Find Stocks
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- CD Calculator: Certificate of Deposit Calculator
- What Does the Future Hold for Eli Lilly?
- How to Calculate Return on Investment (ROI)
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
